Journal article
Ultra-high-field MR-spectroscopy in NAFLD: novel mechanistic and diagnostic insights of energy metabolism in NASH and advanced fibrosis
- Abstract:
-
Background & Aims
With the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) non-invasive tools obtaining pathomechanistic insights to improve risk stratification are urgently needed. We therefore explored high- and ultra-high-field magnetic resonance spectroscopy (MRS) to obtain novel mechanistic and diagnostic insights into alterations of hepatic lipid, cell membrane and energy metabolism across the spectrum of NAFLD.
Methods
MRS and liver biopsy were performed in 30 NAFLD patients with NAFL (n=8) or NASH (n=22). Hepatic lipid content and composition were measured using 3-Tesla proton (1H)-MRS. 7-Tesla phosphorus (31P)-MRS was applied to determine phosphomonoester (PME) including phosphoethanolamine (PE), phosphodiester (PDE) including glycerophosphocholine (GPC), phosphocreatine (PCr), nicotinamide adenine dinucleotide phosphate (NADPH), inorganic phosphate (Pi), γ-ATP and total phosphorus (TP). Saturation transfer technique was used to quantify hepatic ATP flux.
Results
Hepatic steatosis in 1H-MRS highly correlated with histology (P<.001) showing higher values in NASH than NAFL (P<.001) without differences in saturated or unsaturated fatty acid indices. PE/TP ratio increased with advanced fibrosis (F3/4) (P=.002) whereas GPC/PME+PDE decreased (P=.05) compared to no/mild fibrosis (F0-2). γ-ATP/TP was lower in advanced fibrosis (P=.049), while PCr/TP increased (P=.01). NADPH/TP increased with higher grades of ballooning (P=.02). Pi-to-ATP exchange rate constant (P=.003) and ATP flux (P=.001) were lower in NASH than NAFL.
Conclusions
Ultra-high-field MRS, especially saturation transfer technique uncovers changes in energy metabolism including dynamic ATP flux in inflammation and fibrosis in NASH. Non-invasive profiling by MRS appears feasible and may assist further mechanistic and therapeutic studies in NAFLD/NASH.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 733.6KB, Terms of use)
-
- Publisher copy:
- 10.1111/liv.13451
Authors
- Publisher:
- Wiley
- Journal:
- Liver International More from this journal
- Volume:
- 37
- Issue:
- 10
- Pages:
- 1544–1553
- Publication date:
- 2017-05-20
- Acceptance date:
- 2017-03-19
- DOI:
- EISSN:
-
1478-3223
- ISSN:
-
1478-3231
- Keywords:
- Pubs id:
-
pubs:695532
- UUID:
-
uuid:8b8b660e-dca2-4daa-bfc6-5a95e32670c4
- Local pid:
-
pubs:695532
- Source identifiers:
-
695532
- Deposit date:
-
2017-05-17
- ARK identifier:
Terms of use
- Copyright holder:
- Traussnigg et al
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors Liver International Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
If you are the owner of this record, you can report an update to it here: Report update to this record